P D Stricker
Overview
Explore the profile of P D Stricker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Zhang A, Grogan J, Mahon K, Rasiah K, Sved P, Eisinger D, et al.
Ann Oncol
. 2017 May;
28(8):1903-1909.
PMID: 28486686
Background: Prostate cancers (PCs) with similar characteristics at the time of diagnosis can have very different disease outcomes. Conventional biomarkers of PC still lack precision in identifying individuals at high...
3.
Beattie K, Symons J, Chopra S, Yuen C, Savdie R, Thanigasalam R, et al.
J Robot Surg
. 2016 Mar;
7(2):193-9.
PMID: 27000912
Early return of continence forms an important component of quality of life for patients after robotic-assisted radical prostatectomy (RALP). Here we describe the steps of bladder neck imbrication and vesico-urethral...
4.
Thompson J, van Leeuwen P, Moses D, Shnier R, Brenner P, Delprado W, et al.
J Urol
. 2015 Nov;
195(5):1428-1435.
PMID: 26529298
Purpose: We assess the accuracy of multiparametric magnetic resonance imaging for significant prostate cancer detection before diagnostic biopsy in men with an abnormal prostate specific antigen/digital rectal examination. Materials And...
5.
Ting F, Tran M, Bohm M, Siriwardana A, van Leeuwen P, Haynes A, et al.
Prostate Cancer Prostatic Dis
. 2015 Oct;
19(1):46-52.
PMID: 26458959
Background: Current data on the use of irreversible electroporation (IRE) in the treatment of prostate cancer (PCa) is limited. We aim to evaluate the safety, short-term functional and oncological outcomes...
6.
Valerio M, Stricker P, Ahmed H, Dickinson L, Ponsky L, Shnier R, et al.
Prostate Cancer Prostatic Dis
. 2014 Sep;
17(4):343-7.
PMID: 25179590
Background: To evaluate the safety and clinical feasibility of focal irreversible electroporation (IRE) of the prostate. Methods: We assessed the toxicity profile and functional outcomes of consecutive patients undergoing focal...
7.
Selth L, Townley S, Bert A, Stricker P, Sutherland P, Horvath L, et al.
Br J Cancer
. 2013 Jul;
109(3):641-50.
PMID: 23846169
Background: Circulating microRNAs (miRNAs) are emerging as promising biomarkers for prostate cancer. Here, we investigated the potential of these molecules to assist in prognosis and treatment decision-making. Methods: MicroRNAs in...
8.
Stevens M, Stricker P, Saalfeld J, Brenner P, Kooner R, ONeill G, et al.
Australas Radiol
. 2003 Jun;
47(2):152-60.
PMID: 12780444
Combination high dose rate brachytherapy (HDRB) and external beam radiation therapy is technically and clinically feasible as definitive treatment for localized prostate cancer. We report the first large Australian experience...
9.
Quinn D, Henshall S, Haynes A, Brenner P, Kooner R, Golovsky D, et al.
J Clin Oncol
. 2001 Aug;
19(16):3692-705.
PMID: 11504751
Purpose: Although predicting outcome for men with clinically localized prostate cancer (PC) has improved, the staging system and nomograms used to do this are based on results from the North...
10.
Horvath L, Henshall S, Lee C, Head D, Quinn D, Makela S, et al.
Cancer Res
. 2001 Jul;
61(14):5331-5.
PMID: 11454669
The role of estrogen and its receptors in the etiology and progression of prostate cancer (PC) is poorly understood. In normal and malignant human prostate, estrogen receptor-alpha is expressed only...